HeXun Biosciences Co (ROCO:6986) Total Liabilities: NT$80.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6986 HeXun Biosciences Co Ltd ROCO:6986
22 GF Score
Price NT$43.70
! 2 Warning Signs
View Full Analysis

What is HeXun Biosciences Co Total Liabilities?

HeXun Biosciences Co ROCO:6986 22 Total Liabilities is NT$80.8 Mil as of Mar. 2026. GuruFocus rates ROCO:6986 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

HeXun Biosciences Co's Total Liabilities for the quarter that ended in Mar. 2026 was NT$80.8 Mil.

HeXun Biosciences Co's quarterly Total Liabilities increased from Sep. 2025 (NT$89.01 Mil) to Dec. 2025 (NT$95.47 Mil) but then declined from Dec. 2025 (NT$95.47 Mil) to Mar. 2026 (NT$80.84 Mil).

HeXun Biosciences Co's annual Total Liabilities declined from Dec. 2023 (NT$98.07 Mil) to Dec. 2024 (NT$86.34 Mil) but then increased from Dec. 2024 (NT$86.34 Mil) to Dec. 2025 (NT$95.47 Mil).

HeXun Biosciences Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for HeXun Biosciences Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeXun Biosciences Co Total Liabilities Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 79.87 89.28 98.07 86.34 95.47

HeXun Biosciences Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 98.98 89.01 95.47 80.84
ROCO:6986
22GF Score
HeXun Biosciences Co Ltd ROCO:6986
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeXun Biosciences Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

HeXun Biosciences Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=62.544+(32.622+0.30200000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=95.5

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=837.065-741.597
=95.5

HeXun Biosciences Co's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=48.818+(31.719+0.302
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=80.8

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=851.143-770.304
=80.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$80.8 Mil mean?
HeXun Biosciences Co (ROCO:6986) has a Total Liabilities of NT$80.8 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for HeXun Biosciences Co and its competitors.
Is HeXun Biosciences Co's Total Liabilities too high?
HeXun Biosciences Co's current Total Liabilities is NT$80.8 Mil. Overall, HeXun Biosciences Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does HeXun Biosciences Co's Total Liabilities compare to VRTX and REGN?
HeXun Biosciences Co's Total Liabilities of NT$80.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for HeXun Biosciences Co and its competitors. HeXun Biosciences Co's current Total Liabilities is NT$80.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeXun Biosciences Co stock overvalued right now?
HeXun Biosciences Co (ROCO:6986) has a current Total Liabilities of NT$80.8 Mil. The current Total Liabilities is NT$80.8 Mil. HeXun Biosciences Co's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For HeXun Biosciences Co (ROCO:6986), the current Total Liabilities is NT$80.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeXun Biosciences Co Business Description

Address Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.
22GF Score

Get the complete analysis for ROCO:6986

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$43.70
Price